Isolation of a new melanoma antigen, MART-2, containing a mutated epitope recognized by autologous tumor-infiltrating T lymphocytes.
about
Identification of bladder cancer antigens recognized by IgG antibodies of a patient with metastatic bladder cancer.Novel melanoma antigen, FCRL/FREB, identified by cDNA profile comparison using DNA chip are immunogenic in multiple melanoma patients.Identification of a glioma antigen, GARC-1, using cytotoxic T lymphocytes induced by HSV cancer vaccine.Genomic variation in seven Khoe-San groups reveals adaptation and complex African history.Progress in the development of immunotherapy for the treatment of patients with cancer.Transfer of a TCR gene derived from a patient with a marked antitumor response conveys highly active T-cell effector functions.A peptide antigen derived from EGFR T790M is immunogenic in non‑small cell lung cancerA listing of human tumor antigens recognized by T cells: March 2004 update.Identification of human tumor antigens and its implications for diagnosis and treatment of cancer.Immunological detection of altered signaling molecules involved in melanoma development.Cancer immunotherapy targeting neoantigens.The immunological era in melanoma treatment: new challenges for heat shock protein-based vaccine in the advanced disease.Antigen-specific versus antigen-nonspecific immunotherapeutic approaches for human melanoma: the need for integration for optimal efficacy?Heat-shock proteins-based immunotherapy for advanced melanoma in the era of target therapies and immunomodulating agents.HLA-binding properties of tumor neoepitopes in humans.The future of immunotherapy for sarcoma.Immune targets and neoantigens for cancer immunotherapy and precision medicine.Human Tumor Antigens and Cancer Immunotherapy.Design of enhanced agonists through the use of a new virtual screening method: application to peptides that bind class I major histocompatibility complex (MHC) molecules.MicroRNAs Reprogram Tumor Immune Response.Recent Advances in Targeting CD8 T-Cell Immunity for More Effective Cancer Immunotherapy.
P2860
Q33196260-5BAC4AB0-5686-49E2-BC47-D1E484DC6AD2Q33209095-BAE41FD2-527C-4EFC-BD5A-65D41D0D115CQ33223046-3A4B680E-3F2F-45C4-97EA-C80E50F237E9Q34300968-1CFA798A-2DF2-4B7E-8C09-B922C0A4442BQ34570245-A12BDBCC-DA82-442B-A870-D3887255C680Q34669675-2753F0AD-D3DF-4190-91B1-546351A6A44DQ34775850-B02F2D26-A293-4E09-862F-55AB3DF31D5DQ35862179-0DD40D2B-8854-4B9D-AE16-5758C01BF131Q35927479-94D64166-E190-4100-B0A0-1A68E18A3681Q36178394-32DE7286-E12D-44D5-9453-878EA85C8415Q36889067-4ED76E6C-63F8-49BF-B2E7-C6D330C3AE2AQ37908142-839B1DB0-759F-4915-9637-10E08EFD91BAQ37952804-8EE8E4A1-2EBE-424F-84BD-BC654444CF33Q38199545-88C10883-08AC-41A3-BAD7-2F3A4E61E16EQ38217357-E81607B1-C188-4A53-B71E-DD62727A1A6CQ38829558-10A929B7-6839-454C-92E9-043FBFCD3DDCQ39057617-0127D40A-9E15-463C-8EC0-7B400F45DAB4Q41533232-7705CBDD-703B-4DE6-8592-D0FD1408B135Q43093883-A9E21B0A-9B1F-4044-B0BB-6A4B0BA84D87Q45873784-8AE43054-86FA-46A8-A690-5F3992B9F2F2Q49432766-3CA4FFD3-12A4-4E03-99D4-696349507CD2
P2860
Isolation of a new melanoma antigen, MART-2, containing a mutated epitope recognized by autologous tumor-infiltrating T lymphocytes.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Isolation of a new melanoma an ...... or-infiltrating T lymphocytes.
@ast
Isolation of a new melanoma an ...... or-infiltrating T lymphocytes.
@en
type
label
Isolation of a new melanoma an ...... or-infiltrating T lymphocytes.
@ast
Isolation of a new melanoma an ...... or-infiltrating T lymphocytes.
@en
prefLabel
Isolation of a new melanoma an ...... or-infiltrating T lymphocytes.
@ast
Isolation of a new melanoma an ...... or-infiltrating T lymphocytes.
@en
P2093
P1476
Isolation of a new melanoma an ...... or-infiltrating T lymphocytes.
@en
P2093
Fitzgerald E
Kawakami Y
Rosenberg S
Sumimoto H
P304
P356
10.4049/JIMMUNOL.166.4.2871
P407
P577
2001-02-01T00:00:00Z